Latest News about Eli Lilly And Co
Recent news which mentions Eli Lilly And Co
   5 things to know before the stock market opens Monday
   
  
  December 18, 2023
  From CNBC.com News
 
   The weight loss drug boom isn't over yet — here's what to expect in the year ahead
   
  
  December 17, 2023
  From CNBC.com News
 
   Patients regain weight after stopping Eli Lilly's Zepbound, study says
   
  
  December 11, 2023
  From CNBC.com News
 
   Treasury yields inch higher ahead of Fed meeting
   
  
  December 11, 2023
  From CNBC.com News
 
   Biden administration asserts power to seize drug patents in move to slash high prices
   
  
  December 07, 2023
  From CNBC.com News
 From CNBC.com News
 
   Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
   
  
  December 05, 2023
  From CNBC.com News
 
   Cramer says the growing popularity of weight loss drugs brings new investing opportunities
   
  
  December 04, 2023
  From CNBC.com News
 From CNBC.com News
 
   Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
   
  
  December 01, 2023
  From CNBC.com News
 
   Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
   
  
  November 30, 2023
  From CNBC.com News
 
   Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
   
  
  November 27, 2023
  From CNBC.com News
 
   This key element of ESG investing could drive real change at companies and boost returns
   
  
  November 18, 2023
  From CNBC.com News
 
   Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
   
  
  November 13, 2023
  From CNBC.com News
 
   Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
   
  
  November 13, 2023
  From CNBC.com News
 
   Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
   
  
  November 10, 2023
  From CNBC.com News
 
   FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
   
  
  November 08, 2023
  From CNBC.com News
 From CNBC.com News
 
   Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
   
  
  November 02, 2023
  From CNBC.com News
 From CNBC.com News
 
   5 things to know before the stock market opens Monday
   
  
  October 30, 2023
  From CNBC.com News
 From CNBC.com News
 
   Treasury yields continue retreat after 10-year slips back below 5%
   
  
  October 24, 2023
  From CNBC.com News
 
   Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
   
  
  October 23, 2023
  From CNBC.com News
 
   Treasury yields rise again as 10-year hovers near 5%
   
  
  October 23, 2023
  From CNBC.com News
 From CNBC.com News
 
   'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
   
  
  October 14, 2023
  From CNBC.com News
 
   The S&P 500's top 10 performers since its bear market low — and where Cramer stands on them now
   
  
  October 13, 2023
  From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
